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 ABSTRACT 
 
Evaluating the Co-commensal Lifestyles of Staphylococcus aureus and 
Staphylococcus epidermidis 
 
Staphylococcus epidermidis is a ubiquitous skin commensal, and produces a 
serine protease Esp that can eradicate nasal carriage of the opportunistic pathogen, 
Staphylococcus aureus. We evaluated the ability of S. epidermidis and S. aureus to 
express serine protease and compete with one another in response to acidic pH and 
unsaturated free fatty acids; conditions encountered on human skin. The hypervirulent 
USA300 strain of S. aureus was more competitive in co-culture conditions of acidic pH 
or 25 µM palmitoleic acid alone, but could not compete with S. epidermidis when these 
conditions were combined. Conversely, in pure culture, these conditions promoted 
abundant expression of the SspA serine protease by S. aureus, but repressed expression 
of the orthologous Esp protease by S. epiderimidis. Thus, in response to conditions that 
would be encountered on skin, pathogenic S. aureus maintained production of secreted 
virulence factors, but S. epidermidis had a competitive growth advantage. 
 
 
 
KEYWORDS: S. epidermidis, S. aureus, USA300, commensal, pathogen, 
colonization, skin, unsaturated free fatty acid, acidic pH, protease, SspA, Esp, 
staphylococcal proteolytic cascade, bacterial interference 
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CHAPTER 1. LITERATURE REVIEW 
1.1   Introduction 
S. aureus is an opportunistic pathogen notorious for hospital and community 
associated infections, of which soft skin tissue infections are the most prevalent.  
Colonization is essential for the onset of invasive infections and, in colonized skin, S. 
aureus encounters S. epidermidis, a ubiquitous skin commensal (1). This review will 
focus on S. aureus as a pathogen, S. epidermidis as a skin commensal, and their 
competition in occupying the same niche on human skin, with an emphasis on the role of 
secreted proteases. 
1.2 Staphylococcus aureus 
1.2.1 Description  
In 1882 Alexander Ogston described the occurrence of clustered micrococci in 
abscesses and named them staphylococci. The term Staphylococcus is of Greek origin in 
which Staphyle means “bunch of grapes” and kokkos means berry. Two years later, 
Anton J. Rosenback coined the term Staphylococcus aureus, aurum translating to gold in 
Latin, to identify the species that manifests as yellow colonies on agar medium (2).  The 
yellow color results from the production of Staphyloxanthin, a carotenoid pigment used 
to distinguish S. aureus from other staphylococcal species (3, 4). The S. aureus bacterium 
is further described as a gram positive and non-motile with the size of 1μm in diameter.  
Another key characteristic of S. aureus is its ability to coagulate blood plasma. The 
coagulase protein (Coa) binds prothrombin in plasma, leading to the conversion of 
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fibrinogen to fibrin and subsequent clot formation (5). Coagulation is used to distinguish 
coagulase-positive S. aureus from coagulase-negative staphylococci.  
1.2.2 Clinical Significance 
Alexander Ogsten’s recognition of Staphylococcus aureus’s role in infections 
initiated its reign as a major human pathogen.  It is the most common cause of skin and 
soft tissue infections (SSTI), and has been associated with more life threatening diseases 
such as bacteremia, pneumonia and endocarditis, with the potential to induce septic shock 
(6). The use of penicillin, the first β-lactam antibiotic used clinically, in the 1940’s to 
treat S. aureus infections, quickly gave rise to resistant strains. The subsequent treatment 
of these penicillin-resistant S. aureus with methicillin, a modified β-lactam antibiotic, 
resulted in the selection of methicillin resistant S. aureus (MRSA). MRSA continued to 
spread globally beginning in the early 1960’s and caused several epidemics. Presently, 
MRSA collectively refers to multi-drug resistant strains of S. aureus, and has been 
identified as one of the most common causes of nosocomial infections in patients with 
compromised immune systems (6, 7). Although MRSA was a major threat to 
predominantly hospitalized patients as recently as the late 1990’s, it is now causing 
infections among healthy individuals in the community. These community-acquired 
MRSA (CA-MRSA) infections have substantially raised the annual death rate caused by 
infectious diseases presenting at hospitals (7). 
From the general population, approximately 30 to 50% are transient carriers and 
30% are persistent carriers of S. aureus at any given time (6). The organism prefers 
niches such as anterior nares, axillae, and perineum. Colonization has been noted as a risk 
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factor for infections, which are triggered when commensal bacteria breach the skin 
barrier and invade the host (4, 6, 7). The severity of the infection is dependent on the 
virulent nature of the strain and the host’s defense mechanisms (4).  
1.2.3 Human Skin’s Innate Immune Defense  
Human skin acts as a formidable physical and chemical barrier to protect against 
the colonization of potential pathogens. It is comprised of folds and invaginations that 
contain sweat glands (eccrine and apocrine), sebaceous glands and hair follicles. The 
eccrine sweat glands secrete water and electrolytes that regulate skin temperature and 
play a role in the acidification of the skin (pH ~ 4.5-5.9). The apocrine sweat glands 
secrete an odorless substance proposed to contain pheromones. Further, the sebaceous 
glands, connected to hair follicles, secrete sebum containing antimicrobial free fatty acids 
including sapienic acid, linoleic acid and palmitoleic acid (8, 9). The presence of free 
fatty acids has also been implicated in acidifying the skin. These innate defenses inhibit 
growth of potential pathogens while favoring symbiotic commensals (9).  
The skin is also an immunological barrier against invading bacteria. This 
component is vital in managing colonization and infections. Keratinocytes in the stratum 
corneum layer of the epidermis constantly scavenge the microbiota colonizing the skin 
using pattern recognition receptors (PRRs) such as Toll-like receptors, mannose receptors 
and the NOD receptors for pathogen-associated molecular patterns (PAMPs). S. aureus 
PAMPs include peptidoglycan and lipoteichoic acids. Immediately after the keratinocyte 
PRRs are triggered, antimicrobial peptides are produced and phagocytosis is activated by 
cytokines and chemokines (9). 
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1.2.4 Colonization and Adhesion Factors 
Colonization occurs when the top epithelial layer is traversed and a high affinity 
adherence forms between host extracellular matrix proteins and bacterial cell-surface 
virulence factors known as microbial surface components recognizing adhesive matrix 
molecules (MCSCRAMMS) (10). MCSCRAMMS are covalently anchored to the cell 
wall by S. aureus Sortase A, a transpeptidase protein. Sortase A cleaves the short C-
terminal LPXTG motif between threonine and glycine of MCSCRAMMS, and mediates 
the formation of an amide bond between the carboxyl group of the threonine and the 
pentaglycine cross-bridge in the peptidoglycan layer (11, 12). S. aureus also produces 
Sortase B in the event of iron starvation; Sortase B recognizes the NPQTN motif of the 
Iron-regulated Surface Determinant C (IsdC) protein and anchors it to the cell surface 
(13). 
Many members of the MSCRAMM family have been identified and 
characterized, which include staphylococcal protein A (SpA), clumping factors (ClfA and 
ClfB), fibronectin binding proteins (FnbpA and FnbpB) and collagen binding protein 
(Cna) (14, 15, 16, 17). On the host, SpA binds the Von Willebrand factor and 
immunoglobulin G, ClfA and ClfB both bind fibrinogen, and FnbpA and FnbpB bind 
fibronectin (14, 15, 16). These host ligands are glycoproteins found in the extracellular 
matrix and blood plasma, and play a role in thrombogenesis. The binding of these 
MSCRAMMS to host proteins produces an agglutination phenotype, aids bacterial 
attachment to damaged tissue, and contributes to pathogenesis (10, 18).  Strains of S. 
  5 
aureus implicated in diseases such as osteomyelitis and cellulitis express Cna that adhere 
the bacteria to connective tissue. (17).  
1.2.5 Tissue Invasion and Metastatic Infection 
Colonization by S. aureus is a risk factor for invasive infections, demonstrated by 
findings that patients with S. aureus infections were previous carriers of the same strain 
(6). Invasive infection occurs when S. aureus shifts from attachment to invasive phase by 
breaching the skin barrier and entering the host. This is accompanied by the expression of 
enzymes that include proteases, lipases, hyaluronidases and nucleases (4). S. aureus 
proteases have been shown to promote shedding of the MSCRAMM proteins Fnbp, ClfA 
and ClfB from the cell surface. Degradation of adhesion virulence factors contributes to 
S. aureus’s transition from commensal to pathogen (19, 20). Further, exoproteins lyse 
host cells and break down tissues. The nutrients released from this degradation are used 
for bacterial growth (4). In addition to host invasion factors, S. aureus employs a myriad 
of toxins that promote virulence. The major virulence determinants include hemolysins 
(alpha toxin, beta toxin, delta toxin and gamma hemolysin), Panton-Valentine 
Leukocidin, and phenol soluble modulins. These toxins aid the organism in counteracting 
host immune defenses (21). 
Alpha toxin (Hla) is considered to be the major cytolytic pore forming hemolysin 
that is encoded in the S. aureus core genome (21). Hla targets human macrophages and 
erythrocytes by creating a heptameric, beta-barrel structure in the host cell membrane. 
The binding of Hla to host cells requires the expression of the metalloprotease 10 
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(ADAM10), and interaction between Hla and ADAM10 allows the toxin to manifest 
cytolytic activity (22). Hla, however, is not lytic to neutrophils (21).  
Beta toxin (Hlb), delta toxin (Hld) and gamma hemolysin (Hlg) make up the other 
hemolysins in S. aureus.  Hlb is a sphingomyelinase that displays cytolytic activity in 
erythrocytes based on the sphinogomyelin content of the cell membrane. As a result, it is 
species dependent, displaying more activity towards cow, sheep and goat erythrocytes 
than human erythrocytes. Hld, also a member of the phenol soluble modulins, is a small 
peptide that is lytic towards a broad spectrum of cell types. Finally, gamma hemolysin is 
encoded by the hlgA, hlgB and hlgC genes into the 3 respective components: HlgA, HlgB 
and HlgC. Hlg is a bi-component toxin that exists either as HlgA+HlgB or HlgB+HlgC. 
Gamma hemolysin promotes leukotoxic activity but shows weak hemolytic activity (23). 
Panton-Valentine Leukocidin (PVL) is a phage encoded toxin with LukS-PV and 
LukF-PV components; the initial binding of LukS-PV to its receptors triggers the binding 
of LukF-PV (21). Similar to Hla, the PVL toxin also forms barrel shaped pores in the host 
cell membrane, and is primarily cytotoxic to neutrophils. A recent study demonstrated 
that binding of LukS-PV to the C5a receptor in the C5 complement system causes 
inhibition of neutrophil chemotaxis to the site of infection (24). Further, PVL is known to 
cause substantial pro-inflammatory effects (21). 
Phenol soluble modulins (PSM) belong to a family of amphipathic, alpha helical 
peptides. PSMα and PSMβ are the two major types of PSMs identified in S. aureus, of 
which PSMα shows significantly more cytolytic properties than PSMβ. These virulence 
factors target neutrophils and erythrocytes in the host. PSMα1 and PSMα4 also show 
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antimicrobial activity against Streptococcus pyogenes (21, 25). Surewood et al. have 
recently shown that S. aureus cells express PSMs after they are phagocytosed, and lyse 
the neutrophil phagosomes from within to escape (26). Further, PSMs have been 
implicated in promoting biofilm structure and integrity by self-assembling into fibril-like 
structures, while also contributing to biofilm disassembly due to their surfactant like 
properties (27, 28). Additionally, another PSM peptide, PSM-mec, is the only PSM to be 
encoded on a mobile genetic element. It modulates virulence in certain strains of MRSA 
(29). Its significance will be discussed in a later section. 
In addition to the aforementioned factors that contribute to S. aureus virulence 
within the vicinity of the bacteria, S. aureus can also produce toxins that act to induce 
disease in the absence of the bacteria itself (6). Toxic shock syndrome is an example in 
which S. aureus releases toxic shock syndrome toxin-1 (TSST-1) into the blood stream 
from a colonization site. Toxic shock syndrome causes toxinosis in the host and can be 
fatal. (4).  
Expression of virulence factors is crucial for the success of S. aureus in 
establishing metastatic infection by spreading to the bones, joints, and vital organs such 
as kidneys and lungs. The exact mechanisms of bacterial dissemination from local 
infection sites has not been elucidated. Nonetheless, once in the blood, S. aureus can 
spread quickly to distant sites resulting in septicemia and, in severe cases, sepsis can 
progress to multi-organ failure and death (4,6). 
1.2.6 Immunoevasive Strategies 
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Staphylococcus aureus is equipped with an arsenal of virulence factors that allow 
it to escape host innate and adaptive immunity. These factors can be categorized 
according to the different mechanisms that promote host immune evasion, which include 
inactivation of host bactericidal components, avoidance of opsonization, prevention of 
antimicrobial peptide (AMP) activity, and inactivation of complement systems. 
Additionally, biofilms are a means by which S. aureus communities evade the host 
immune defense (30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40).  
Staphyloxanthin, catalase, cell wall anchored teichoic acids (WTA) and fatty acid 
modifying enzyme (FAME) are factors that inactivate host bactericidal components (30, 
31, 32, 33). Staphyloxanthin is a membrane bound carotenoid pigment produced by S. 
aureus. In addition to giving S. aureus its characteristic yellow color, it acts as a 
biological antioxidant by scavenging and detoxifying reactive oxidative species (ROS) 
produced by human neutrophils, such as H2O2, O2
- and ClO- (30).  Catalase is also a 
membrane bound protein that breaks down host produced H2O2 into H2O and O2 (31). 
WTA and FAME are both involved in targeting antimicrobial fatty acids found on skin. 
Recently, Kohler et al. have shown that WTA prevent the binding of antimicrobial free 
fatty acids to the bacterial cell surface and allow bacteria to colonize skin (32). FAME is 
a secreted protein found on the skin and in abscesses, which catalyzes the esterification of 
long-chain free fatty acids to alcohol and cholesterol. In this manner, it can inactivate the 
bactericidal activity of lipids (33).  
Antimicrobial peptide sensing (Aps) system is a mechanism by which S. aureus 
evades AMP activity. It is a histidine/kinase sensor and regulator system that controls the 
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expression of resistance mechanisms against host AMPs. These mechanisms include 
altering the membrane charge by D-alanylation of teichoic acids and incorporating 
phosphotidylglycerol on the membrane to avoid binding of the positively charged AMPs, 
and by expressing efflux pumps to remove AMPs from the bacterial surface (34).  
Staphylococcal Protein A (SpA), staphylococcal IgG-binding protein (Sbi), 
staphylokinase (SAK) and capsular polysaccharide are factors S. aureus use to prevent 
opsonization (35, 36, 37, 39). SpA binds the Fc component of immunoglobulin G in 
blood plasma, and prevents the binding of antibodies to bacterial antigens for subsequent 
opsonization (35). Sbi, identified by Zhang et al., also shows similar binding specificity 
as SpA. (36). Staphylokinase binds to plasmin and activates plasminogen in blood 
plasma. This complex then mediates degradation of immunoglobulin G and opsonic C3b, 
preventing phagocytosis. Staphylokinase is further involved in dissolving fibrin clots and 
disseminating bacteria (39). Most clinical strains of S. aureus also produce a 
polysaccharide microcapsule of serotype 5 or 8. This capsule allows S. aureus to prevent 
host detection of bacterial cell surface proteins responsible for triggering immune 
responses (37). 
Two factors that aid S. aureus in inactivating host complement systems include 
chemotaxis-inhibiting protein of Staphylococcus aureus (CHIPS) and staphylococcal 
complement inhibitor (SCIN). CHIPS interferes with the host C5 complement system. It 
binds C5a opsonic receptor, C5aR, on neutrophils and prevents chemotaxis of neutrophils 
to site of infection. SCIN, also a complement system deactivator, interacts with the C3 
complement system by disabling the C3 convertase and preventing C3b deposition and 
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opsonization of bacteria (38).  
Finally, biofilm is made up of a bacterial community adhered to a surface. 
Biofilm formation occurs in three stages: i) attachment of cells to the host extracellular 
matrix via MSCRAMM family of proteins, ii) proliferation and accumulation into a 
microcolony by the incorporation of polysaccharide intercellular adhesion (PIA) and 
extracellular DNA into an intricate polymeric matrix, and iii) maturation. Following 
maturation phase, bacteria transition between biofilm and planktonic phase based on 
quorum sensing systems. S. aureus form robust biofilms, and the dense nature of these 
microbial colonies protect the bacteria from host immune defenses (40, 41).  
1.2.7 Virulence Regulation 
The coordinated expression of cell-surface and secreted virulence factors is 
controlled by global regulatory systems.  Similar to other pathogens, S. aureus expresses 
these in the form of two component systems (TCS), comprised of sensory and regulatory 
modules, and transcriptional regulators. There are sixteen characterized TCS in S. aureus, 
of which five pertaining to virulence will be discussed in this section (42). Also 
mentioned are some of the major transcriptional regulators employed by S. aureus. 
The accessory gene regulator (Agr) is the most widely characterized TCS in S. 
aureus. It functions as a quorum sensing system activated by high cell density in late 
exponential growth phase. The agr locus is comprised of promoter P2, which governs the 
transcription of agrBDCA, and promoter P3, which controls transcription of RNA III (the 
effector molecule involved in gene regulation). AgrD is a propeptide that is post 
transcriptionally modified into an autoinducing peptide (AIP) and secreted by the 
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membrane traversing endopeptidase, AgrB. When AIP levels reach threshold, AgrC, a 
histidine kinase membrane protein, autophosphorylates and transfers the phosphate to 
AgrA, the response regulator. AgrA subsequently binds promoters P2 and P3, and 
initiates transcription. S. aureus strains express four different Agr types due to variations 
in the agrB, D and C regions. The AIP expressed by each type is sequence specific, only 
stimulating its own Agr type and inhibiting other types. RNA III transcription leads to the 
up-regulation of infectious stage toxins and enzymes including hemolysins, lipases, 
nucleases and proteases, and the down-regulation of adhesion proteins (43, 44). 
SaeRS, ArlRS, SrrAB, and WalKR also control the regulation of virulence factors 
in S. aureus (45, 46, 47, 48, 49, 50). Of these, SaeRS is the second major TCS virulence 
regulator. The agr locus up-regulates saeRS transcription while acidic pH and high 
concentrations of sodium chloride conditions repress transcription (45). SaeRS controls 
expression of secreted virulence factors such as hemolysins, nucleases and DNAases, 
some of which overlap with the Agr regulon and production of adhesion factors such as 
FnbpA (45, 46). SaeRS also induces production of immune evasion proteins (47). 
Another TCS, ArlRS represses agr expression and in turn decreases production of 
secreted virulence factors (48). Further, the TCS SrrAB represses secretion of virulence 
factors under anaerobic environmental conditions. Hence it is involved in the regulation 
of energy metabolism. SrrAB also inhibits RNA III transcription under micro-aerobic 
stimuli (49). Ulrich et al. demonstrated that SrrAB plays a role in increasing production 
of polysaccharide elements involved in biofilm formation (50). WalKR is yet another 
TCS that was recently shown to be involved in the transition of S. aureus from 
commensal to pathogen mode and cell wall metabolism. WalKR induces cell wall 
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degradation that results in recruitment of inflammatory response factors, and up-regulates 
expression of saeRS to evade innate immune response (47).  
The two main transcriptional regulators of S. aureus are the staphylococcal 
accessory regulator (Sar) family of transcriptional regulators and the alternative sigma B 
factor (σB) (51, 52). The Sar family is comprised of several homologous DNA binding 
proteins including SarA, R, S, T, U and V. SarA is the most studied of the family and 
hence will be discussed in this section. In post exponential growth, SarA either directly 
acts to increase production of secreted proteins such as hemolysin toxins, or induces 
transcription of the agr locus. SarA also promotes production of adhesion proteins such 
as Fnbp. Furthermore, SarA stimulates S. aureus biofilm formation by increasing 
expression of the biofilm associated protein (Bap) (51). The σB transcriptional factor is 
activated under environmental stress. It up-regulates cell surface proteins and represses 
secreted proteins. σB partially controls the up-regulation of SarA in late exponential phase 
(52). Furthermore, repressor of toxins (Rot) is a transcriptional regulator that works in an 
additive manner to SarA in suppressing expression of secreted proteins. Rot is repressed 
in a σB dependent manner in late growth phase (53).  
1.2.8 Antibiotic Resistance  
The acquisition of antibiotic resistance mechanisms by S. aureus poses a serious 
therapeutic challenge for the clinical community. Penicillin was subscribed as a potential 
treatment for S. aureus infections in the early 1940’s (54). The activity of penicillin is 
dependent upon a beta lactam ring that binds the penicillin binding protein (PBP2) of S. 
aureus and prevents cross-linkage in the bacterial peptidoglycan layer (55).   Incidentally, 
  13 
penicillin-resistant S. aureus strains emerged shortly after the introduction of penicillin, 
and caused a pandemic in the 1950’s. S. aureus acquired a plasmid harboring the beta-
lactamase enzyme required to hydrolyze the amide bond in the beta lactam ring and 
rendered the drug inactive. Methicillin, a derivative of penicillin, was developed in 1959 
to counteract penicillin-resistance. This drug was resistant to inactivation by bacterial 
beta-lactamases. However, methicillin resistant (MRSA) strains emerged within two 
years of use, where the acquisition of a modified PBP2 protein, known as PBP2a, created 
less affinity for all classes of beta-lactam drugs. The mecA gene encodes for PBP2a on 
the staphylococcal cassette chromosome mec (SCCmec).  SCCmec is a mobile genetic 
element (MGE) proposed to have undergone horizontal gene transfer from coagulase 
negative staphylococci into S. aureus. There are currently eleven types of SCCmec 
identified and they range in size from 21 to 67 kbp. SCCmec type II is one of the larger 
ones while SCCmec type IV is on the smaller end. All SCCmec types harbor the mecA 
gene and ccr genes for integration into and excision from the chromosome. A few types 
including type II and III also harbor genes encoding for additional antibiotic resistance 
determinants (54).  
MRSA infections were primarily of clinical origin until the early 1990’s, when 
reports of healthy individuals in the community having contracted invasive MRSA 
emerged (7). Resultantly, MRSA strains are now categorized into hospital acquired 
MRSA (HA-MRSA) and community acquired MRSA (CA-MRSA), based on 
environment of disease onset (56). A CA-MRSA infection is traditionally defined as one 
that occurs outside of a clinical setting, or within 48 h of being admitted to a hospital, 
given that the patient is devoid of HA-MRSA risk factors including surgical procedures, 
  14 
residency in a long-term care facility, indwelling catheter at the time of culture, or 
hospitalization within the past year. HA-MRSA are associated with SCCmec type I, II 
and III, while CA-MRSA are associated with types IV, V and VII, with type IV being the 
dominant one. HA-MRSA strains are commonly multi-drug resistant, hence they carry 
antibiotic resistance elements. The fitness cost engendered by carrying more genetic 
material in HA-MRSA is offset by its tolerance of the high antibiotic selection pressure 
within hospital environments. Meanwhile, CA-MRSA strains are more susceptible to 
antibiotics, but display increased transmissibility between individuals by carrying smaller 
genetic material in their SCCmec (57, 58). Recently, studies have shown that CA-MRSA 
strains now cause invasive infections in hospital settings, blurring the distinction between 
the two categories (56). 
1.2.9 CA-MRSA and USA300 
The earliest reports of CA-MRSA infections in the community were from a 
college football team in Pennsylvania, and among prison inmates in Mississippi and 
California jails (59). As such, key risk factors for contracting CA-MRSA include poor 
hygiene and constant close proximity to others. Although CA-MRSA are notorious for 
causing SSTIs, certain strains have been known to cause more severe diseases. The vast 
majority of CA-MRSA infections are dominated by five clones, including the Midwest 
clone, Southwest Pacific clone, Taiwan clone, European clone, and the USA300 clone. 
Of these, USA300 is the most prevalent strain currently on the verge of causing a global 
epidemic (59). USA300, designated for its unique DNA profile generated by pulse-field 
gel electrophoresis, emerged in the early 2000’s. In addition to causing SSTI, it is also 
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associated with endocarditis, pneumonia, sepsis and necrotizing fasciitis. USA300 
currently accounts for a large percentage of infections caused by S. aureus in the 
community (7).  The elevated virulence and transmissibility of this particular clone has 
been attributed to the acquisition of the arginine catabolic mobile element (ACME), a 
unique marker of USA300 among S. aureus strains, and increased expression of toxins 
(60, 61). 
ACME is encoded on a large MGE presumed to have gone through horizontal 
gene transfer from the coagulase-negative S. epidermidis. Type-1 ACME is integrated 
into the chromosome downstream of the SCCmec type IV characteristic of USA300. 
ACME encodes the arginine deiminase system (arc) and the oligopeptide permease (opp-
3) gene clusters. L-arginine is a substrate for the production of nitric oxide in innate and 
adaptive immunity and the Arc system depletes L-arginine, thereby inhibiting nitric oxide 
generation. Furthermore, ammonia released in this process raises intracellular pH 
allowing S. aureus colonization of the acidic environment found on skin. The opp-3 gene 
encodes proteins in the ABC transporter family that have a range of functions involved in 
nutrient uptake, quorum sensing, host cell adherence, and resistance to antimicrobial 
peptides (60, 62). Recently, Thurlow et al. identified ACME-encoded 
spermidine/spermine acetyltranferases (SpeG) that further contribute to USA300 
survival. Polyamines, derived from arginine, are key components of the skin immune 
response, in which they contribute to wound healing and cell proliferation following 
inflammation. S. aureus cells are extremely susceptible to polyamines and are rapidly 
killed when exposed to physiological levels of spermidine (spd). However, the SpeG 
enzyme confers resistant to polyamines in USA300. As such, ACME heightens the 
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capacity of USA300 to grow, survive and spread in the community where selective 
antibiotic pressures are not encountered (56, 60, 63).   
The overexpression of the PVL toxin is also characteristic of most CA-MRSA 
strains including USA300. Although PVL-positive strains have been reported to cause 
necrotizing fasciitis and pneumonia, much controversy exists surrounding the toxin’s 
contribution to CA-MRSA pathogenicity. A myriad of studies have shown that PVL is 
not linked to morbidity or mortality in murine models (64). Recently, Loffler et al. 
conducted studies on the effects of PVL on neutrophils from various species and 
concluded that PVL promotes lysis of human and rabbit neutrophils but not mouse 
neutrophils.  Though some groups have shown the development of severe SSTIs in rabbit 
models when exposed to PVL-positive strains in comparison to PVL-negative strains, 
other groups have demonstrated no significant differences (65). These results may be 
attributed to variation in study designs. Nonetheless, much unresolved controversy exists 
in regards to PVL’s role as a virulence determinant. 
The elevated expression of other toxins has also been noted in USA300.  It 
produces significant levels of alpha toxin as a result of increased activity of the Agr 
virulence regulator (66). Additionally, USA300 secretes substantially high concentrations 
of PSMα peptides. This phenomenon has been attributed to the lack of PSM-mec 
peptides in CA-MRSA strains. The psm-mec gene is encoded on the SCCmec MGE in 
HA-MRSA strains and suppresses PSMα expression by blocking translation of AgrA 
(29). A group has recently demonstrated the secretion of PSMα derivatives, which are 
PSMα peptides cleaved by the metalloprotease aureolysin. Truncated PSMα peptides 
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display antimicrobial properties against other gram-positive organisms that allow S. 
aureus to be competitive in establishing colonization on human skin (67) 
1.2.10 Staphylococcal Proteolytic Cascade and Papain Family of Proteases 
Proteases play important roles in a pathogen’s transition from colonization to 
infectious phase, and disease progression. In S. aureus, the metalloprotease aureolysin, 
the serine protease SspA, the cysteine protease SspB and the staphostatin SspC 
collectively encompass the well-characterized staphylococcal proteolytic cascade (SPC). 
The genes for sspA, sspB and sspC are encoded on the same operon (sspABC). 
Aureolysin, encoded by aur downstream of sspABC, initiates the cascade with 
autocatalytic processing into its mature form, which then activates SspA, which 
subsequently activates SspB. SspC is an inhibitor of SspB (68, 69). 
Aureolysin belongs to the family of M4 metalloproteases. It is secreted as a 56 
kDa propeptide that undergoes rapid autocatalytic activation by self-cleavage of the 
fungalysin-thermolysin propeptide domain, resulting in the mature 33 kDa protein 
consisting of a Zn2+ ion in its glutamate active site (70). Aureolysin shows preference to 
cleave sites with hydrophobic amino acids at the P1 position. It is shown to be involved 
in the processing of a myriad of enzymes (70, 71). Recently, a group demonstrated the 
role of aureolysin in regulating the secreted virulence repertoire of S. aureus in 
osteomyelitis. In the same study, aureolysin was shown to control degradation of PSMα 
peptides that kill osteoblasts and cause morbidity (72). 
SspA, also known as the V8 glutamyl endopeptidase, is secreted as an inactive 
zymogen. The propeptide is partially auto-processed by intramolecular cleavage within 
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the glutamine rich amino acid segment, with a preference for Gln43.  This initial 
processing is required for aureolysin to cleave at Leu58 and Val69 residues. Following 
aureolysin cleavage, mature SspA is released. SspA shows a preference for cleavage of 
glutamic acid residues at the carboxy terminus. It is implicated in the degradation of 
microbial adhesion proteins and plays a role in the dissemination of S. aureus within the 
host (68, 73). 
SspB, also denoted as staphopain B, is processed into its 20 kDa mature form by 
SspA. However, it is not the only staphopain protease in S. aureus. ScpA, staphopain A, 
is encoded by the scpAB operon with ScpB, staphostatin B, as the inhibitor of ScpA. 
Unlike the SspB, the ScpA precursor undergoes rapid autocatalytic activation (74). 
Premature activation is prevented by ScpB inhibition of the proScpA zymogen (75). 
SspB and ScpA have similar three-dimensional structures and adhere to substrate 
specificity of P2-glycinealanine/serine (where P2 is leucine for ScpA and 
phenylalanine for SspB). However, staphopain proteases have relaxed substrate 
specificities such that amino acid sequences that do not completely adhere to the 
mentioned sequence motifs are cleaved (75, 76). S. aureus autolysin, Atl, is secreted in a 
precursor form that is processed into the 62 kDa amidase and the 51 kDa 
glucosaminidase domains. Oshida et al. recognized that the cleavage sites on Atl 
represent the sequence motif preference of staphopain proteases. This association has not 
been previously explored (77, 78). Staphopain proteases are involved in the degradation 
of cell surface proteins and the processing of kinninigen in blood plasma. Recently, both 
SspB and ScpA have been shown to inhibit innate immune system recruitment to 
inflammation sites by the deactivation of neutrophil chemotaxis receptors (69, 75, 79).  
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Our lab has recently demonstrated the induction of SPC in response to long chain 
unsaturated free fatty acids such as linoleic and palmitoleic acid  (found on the skin or in 
abscesses). USA300 in particular exhibits a strong production of these proteases. This 
phenomenon may aid S. aureus in degrading antimicrobial peptides and producing PSM 
derivatives to establish competitive colonization on the skin (80). 
1.3 Commensal Staphylococcus epidermidis 
1.3.1 Description  
German scientist Anton Rosenbach first coined the term Staphylococcus albus, 
albus meaning white in Latin, to distinguish its characteristic white colonies from the 
yellow colonies formed by S. aureus on media. Since then, Staphylococcus albus has 
been renamed Staphylococcus epidermidis (2). S. epidermidis is non-motile, gram-
positive, and grows as a cluster of cocci. Each coccus is 0.5-1 μm in diameter. S. 
epidermidis displays non-hemolytic properties on blood media and is also differentiated 
from S. aureus by the coagulase test, for which S. epidermidis is negative and S. aureus is 
positive.  
1.3.2 Significance  
S. epidermidis is considered an important opportunistic pathogen, where it has the 
capacity to cause severe chronic infections when it breaches the epithelial layer in 
predisposed hosts. S. epidermidis has been identified as the leading cause of device-
related infections in clinical settings, especially indwelling catheters (1). However, S. 
epidermidis is first and foremost a skin colonizer, as per its species name. It is commonly 
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classified as a commensal that ubiquitously occupies human skin (9). Our review of S. 
epidermidis will reflect its commensal lifestyle and inevitable competition with S. aureus 
on human skin. S. aureus colonizes areas such as the nasal cavities, axillae and perineum, 
in which it will always encounter S. epidermidis and engage in niche competition with 
the native commensal (1). 
1.3.3 Distinguishing Clinical vs. Commensal S. epidermidis Strains 
Commensal and clinical S. epidermidis strains vary in their manifestation of 
virulence mechanisms. Currently, very little is known regarding the genetic determinants 
that distinguish commensal from clinical S. epidermidis. Many groups have noted the 
increased frequency of the icaADBC operon in clinical S. epidermidis strains (81, 82, 83, 
84). Multilocus sequencing was performed on ica-positive and ica-negative S. 
epidermidis strains for clonal analysis. It was found that both ica type isolates clustered 
within a single clonal complex of which a specific sequence type, ST27, encompassed the 
majority of clinical ica-positive strains (83).  The gene products of the icaADBC operon 
synthesize polysaccharide intercellular adhesion (PIA), the main adhesive component in 
biofilms (85). Clinical S. epidermidis infections are predominantly biofilm-associated, 
and dependent upon factors such as PIA to cause robust colonization of medical devices. 
However, biofilm formation has limited advantages for commensal bacteria. Rogers et al. 
have demonstrated that ica-negative S. epidermidis strains were able to outcompete ica-
positive strains when inoculated on human skin. They concluded that the carriage of the 
ica operon incurs a fitness cost that is not expended by skin dwelling S. epidermidis 
strains, hence they are often ica-negative. (81). Further, a few epidemiological studies 
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have verified the presence of the IS256 insertion sequence element in S. epidermidis 
strains that are linked to biofilm formation and invasive infections. Consequently, IS256 
is emerging as a molecular marker for clinical strains (83, 86).  
1.3.4 Colonization and Immune Evasion 
S. epidermidis employs a variety of mechanisms that allow for attachment to and 
prolonged persistence on skin. As in S. aureus, MSCRAMM’s are involved in adhering 
S. epidermidis cells to the extracellular matrix of the host (1). A few of the important 
MSCRAMMs involved include Fbe and SdrG that bind fibrinogen, Embp that binds 
fibronectin, GehD (lipase) that binds collagen, AtlE  (autolysin) that binds vitronectin, 
and Aae that binds fibronectin, fibrinogen and vitronectin (87, 88, 89, 90, 91, 92). 
Teichoic acids, either as lipoteichoic acids embedded in the membrane (LTA) or as wall 
teichoic acids (WTC) covalently attached to the peptidoglycan layer, are factors that play 
a role in attachment by binding fibronectin (93). While Fbe, SdrG, Embp and WTA are 
anchored covalently to the peptidoglycan layer, both AtlE and Aae are non-covalently 
attached to the surface and are involved in cell-wall turnover activity (87, 88, 89, 91, 92, 
93). Further, GehD is a secreted protein and LTA is a constituent on the cell wall (90, 
93).  
Additionally, S. epidermidis displays elements to evade host innate immune 
defenses. Poly-γ-glutamic acid (PGA) is a peptide composed of D and L-glutamic acid 
residues that shield S. epidermidis from AMPs and neutrophil killing (94). S. epidermidis 
also secretes a variety of PSM peptides including PSMβ, PSMδ and PSMϒ.  PSMβ 
peptides display surfactant properties that are implicated in biofilm disassembly, while 
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PSMδ and PSMϒ selectively inhibit growth of skin pathogens during colonization (1, 9, 
95, 96). SepA, a secreted protease, is involved in the degradation of AMPs, while the 
extracellular serine protease (Esp) of S. epidermidis is implicated in AMP, fibronectin 
and immune complement factor C5 degradation (1, 97, 98, 99). The antimicrobial 
sensor/regulator three component system, aps-RSX, detects positively charged AMPs and 
renders them inactive (100). S. epidermidis also encodes FAME that allows easy 
colonization of human skin by esterifying antimicrobial free fatty acids to alcohol and 
cholesterol (101). Many of the virulence factors mentioned above are also expressed by 
S. aureus in homologous forms. The comparison between S. epidermidis and S. aureus 
cell-surface and secreted factors mentioned in this review are illustrated in Table 1.1. It is 
key to note that the expression of virulence factors primarily aids S. epidermidis in 
evasion of the host immune defense and colonization (1). In contrast S. aureus is 
equipped with virulence factors that cause tissue invasion and disease propagation. 
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Table 1.1 Comparison of selected virulence factors expressed by S. epidermidis and S. 
aureus 
Function Virulence factor 
S. aureus S. epidermidis 
Binding of fibrinogen ClfA, ClfB Fbe, SdrG, Aae 
Binding of fibronectin FnbpA, FnbpB WTA/LTA, Embp, Aae 
Binding of Von Willebrand factor SpA - 
Binding of collagen Cna GehD 
Binding of vitronectin  - AtlE, Aae 
Cell-wall turn-over activity Atl AtlE 
Immune Evasion SpA, Sbi, SAK, 
Staphyloxanthin, 
catalase, Aps, 
microcapsule, CHIPS 
and SCIN 
PGA, SepA, Esp, Aps-
RSX 
Coverts long-chain fatty acids to cholesterol FAME FAME 
Degradation of fibronectin binding proteins SspA Esp 
Degradation of ClfB and PSMα Aur - 
Varying cytotoxicity towards erythrocytes and/or 
leukocytes  
Hemolysins (alpha, beta, 
delta and gamma toxins) 
- 
Leukotoxic activity, immune evasion PVL - 
Biofilm disassembly, varying cytotoxic activity, niche 
competition during colonization 
PSMα, PSMβ PSMβ, PSMδ, PSMϒ 
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1.3.5 Quorum Sensing during Colonization 
S. epidermidis encodes quorum sensing systems that allow it to regulate 
expression of virulence factors and biofilm formation. Many groups have studied the 
influence of virulence regulation systems such as SarA, σB and the autoinducer 2 (AI-2) 
dependent quorum sensing system, LuxS, in biofilm formation (102, 103, 104) 
Nonetheless, for the purposes of reviewing S. epidermidis as a commensal bacteria, this 
section will review Agr, the predominant quorum sensing system in skin colonization. As 
in S. aureus, Agr is a TCS that senses accumulation of the autoinducing peptide (AIP) in 
the extracellular environment and activates a series of conformational changes, 
culminating in the transcription of RNA III (105). In general, RNA III up-regulates 
secreted virulence factors and down-regulates cell surface associated proteins (105). S. 
aureus strains harbor one of four different Agr types (I, II, III and IV) while S. 
epidermidis strains encode for only one known Agr type. Competition between the two 
organisms is displayed through bacterial inhibition of the different Agr types. S. 
epidermidis AIP seems to be a strong inhibitor of S. aureus Agr types I, II and III, 
allowing S. epidermidis to inhibit virulence expression of many S. aureus strains (106). 
The CA-MRSA strain USA300 encodes for Agr type III, which implies that its Agr 
activity and virulence secretion will be repressed during co-colonization with S. 
epidermidis (106, 107). 
1.3.6 Commensal Lifestyle and Competition with S. aureus 
S. aureus and S. epidermidis both co-colonize the same niche on human skin. S. 
aureus expresses many virulent genes to propagate diseases while S. epidermidis 
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maintains a more benign nature by primarily expressing colonization factors. Hence, both 
organisms harbor shared virulence factors but employ different strategies as a means to 
maintain survival on the skin (108). Although S. epidermidis is normally a benign 
organism, it has the capacity to keep colonization and subsequent infection of S. aureus 
in check. One such mechanism is the bacterial interference mentioned above (107). 
Recently Iwase et al. have attempted to elucidate the exact mechanism by which S. 
epidermidis is able to outcompete S. aureus in the nasal cavities (1, 109). Results showed 
that Esp produced by S. epidermidis has the capacity to degrade S. aureus proteins and 
host receptor proteins involved in biofilm formation and restrict S. aureus colonization of 
the anterior nares (109). However, Krismer and Peschel have shown that staphylococcal 
cells in the nasal cavities prefer detached rather than biofilm mode of growth (110). 
Nonetheless, an interspecies competition between S. aureus and S. epidermidis does 
exist, the details of which need to be further explored. 
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HYPOTHESIS AND OBJECTIVES 
 
HYPOTHESIS 
S. aureus and S. epidermidis will be differentially influenced by acidic pH and 
unsaturated free fatty acid (uFFA) signals found on human skin. 
 
OBJECTIVES 
Objective I: Determine how production of secreted proteins by S. aureus and S. 
epidermidis is influenced by acidic pH and uFFA. 
Objective II: Identify how acidic pH and uFFA affect growth of S. epidermidis relative 
to S. aureus  
Objective III: Assess the ability of S. aureus and S. epidermidis to grow in co-culture 
under the influence of acidic pH and uFFA.  
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CHAPTER 2. MATERIALS AND METHODS 
2.1 Storage and Growth of Strains 
Bacterial strains used in this study were maintained in tryptic soy broth (TSB, 
DifcoTM Laboratories) and 20% glycerol (Biobasic) at -80°C. The strains were streaked 
onto tryptic soy agar plates consisting of 1.5% agar (TSA, DifcoTM Laboratories). The 
single colonies were sub-cultured into 3 mL of TSB in 13 mL culture tubes (BD Falcon) 
and incubated with shaking at 200 rpm for 18 h at 37°C. Erythromycin (10μg/mL), 
kanamycin (50 μg/mL), neomycin (50 μg/mL) and tetracycline (2μg/mL) antibiotics were 
added as required for bacteria with resistance markers. The optical density (OD) of the 
cultures was measured at 600 nm wavelength (OD600) using a Beckman Coulter 
spectrophotometer, and the volume equivalent of 0.01 OD600 was sub-cultured into 25 
mL of TSB in 125 mL flasks (Pyrex) and grown to stationary phase with shaking at 180 
rpm and 37°C. Co-cultures were achieved by sub-culturing a volume corresponding to 
0.01 OD600 from overnight 3 mL pure cultures of both bacteria into 25 mL TSB in 125 
mL flasks. The supernatants were collected and stored at -80°C in 15 ml tubes (Diamed).  
In mimicking skin pH and unsaturated free fatty acid conditions, 25 mL TSB 
cultures were buffered at various pH conditions and/or supplemented with 25 μM 
palmitoleic acid (PA) (Cedarlane Labs) as required. For pH values of 5.5-6, 0.1 M MES 
buffer was used (Sigma) and for pH 7, 0.1 M Tris-Cl buffer was used.  
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Table 2.1 Staphylococcal strains used in this study 
Organism Strain Description Source 
S. aureus RN6390ΔscpAB Laboratory strain of 8325-4 
lineage with scpAB gene 
deletion 
(43) 
S. aureus USA300 LAC CA-MRSA Los Angeles 
county clone  
Barry Kreiswirth 
S. aureus USA300 USA300 LAC strain cured of 
antibiotic resistant plasmid 
David Heinrichs 
S. aureus USA300Δaur USA300 with aur::lacZ  (80) 
S. aureus USA300ΔsspABC USA300 with sspABC operon 
replaced with tc cassette 
(80) 
S. aureus USA300ΔscpAB USA300 deficient in scpAB 
gene 
This study 
S. aureus USA300ΔsspABCΔaur USA300ΔsspABC with 
aur::lacZ 
(80) 
S. aureus USA300ΔsspABCΔaurΔscpAB USA300ΔsspABCΔaur 
deficient in scpAb gene 
This study 
S. aureus Newman MSSA laboratory strain, 
isolated from human infection  
(111) 
S. aureus SH1000 8325-4 NCTC laboratory 
strain with rsbU, positive 
regulator of sigB, restored 
(112) 
S. epidermidis M23864:W2 Characterized by the Human 
Microbiome Project, obtained 
from human skin 
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2.2 Growth Pattern Analysis in Simulated Skin Conditions 
Stock cultures of bacteria were grown on TSA plates and single colonies were sub-
cultured into 3 mL of TSB for overnight growth. The liquid cultures were then sub-
cultured into triplicate 125 mL flasks with 25 mL TSB alone, buffered at pH 6 and/or 
supplemented with 25 μM PA and grown with shaking at 180 rpm and 37°C. The OD600 
of the cultures were measured at hourly time points until a stationary OD600 was reached. 
The data was graphed using the Graphpad PRISM software. 
2.3 SDS-PAGE 
Secreted proteins in culture supernatants were assessed using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) (113). A volume corresponding to 3 
OD600 units of culture supernatants were precipitated using equal volumes of 
tricholoracetic acid (TCA) for 1 h. The protein pellets were subjected to 1 mL of 70% 
ethanol wash twice prior to being re-suspended in 25 μL of 1× Laemmli Loading buffer 
(4× buffer: 240 mM Tris-Cl at pH 6.8, 8% SDS w/v, 40% glycerol v/v, 20% Β-
Mercaptoethanol, 0.01% Bromophenol blue and milli-Q water) and boiled. The 25 μL of 
sample and a pre-stained protein ladder (Frogga Bio) were loaded into an 8% bis-
acrylamide gel and run at 110 volts for approximately 100 min. The separated protein 
bands were stained with Coomassie blue stain. 
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2.4 Western Blot 
Western blotting was performed using protein samples previously separated for SDS-
PAGE, however volumes of 0.05 OD600 from culture supernatants were loaded without 
TCA precipitation. The protein bands from the gels were transferred onto a FluoroTrans 
PVDF membrane (PALL Life sciences) in a system submerged in transfer buffer 
consisting of 200 mL methanol, 14.4 g glycine (OmniPur), 3.03 g of Tris (OmniPur) 
filled to 1 L of ddH2O. The membrane was then incubated overnight with blocking buffer 
(1 g skim milk powder (EMD), 2 mL horse serum (Sigma), filled to 20 mL with 1× 
phosphate buffer solution (10× PBS: 0.01 M KH2PO4, 0.1 M Na2HPO4, 1.37 M NaCl, 
0.027 M KCl at pH 7)). The following morning, the membrane was incubated in 25 mL 
1× PBS supplemented with 0.0005% tween20 (Sigma) (PBST) and 0.5 g skim milk 
powder with 5 uL of rabbit polyclonal antiserum for SspA (Sigma) or alpha toxin 
(Sigma) for 2 h at 4°C and washed four times with PBST for 15 minute time periods. 
Following the washes, the membrane was incubated in 25 mL PBST and 0.5 g skim milk 
powder with 5 uL donkey anti-rabbit IgG IR800 conjugated antibody (Rockland 
Immunochemicals Inc.) for 2 h at 4°C and washed again with PBST three times for 15 
min time periods and in 1× PBS for 10 min prior to being visualized using the Odyssey 
fluorescence scanning system (Li-Cor, Lincoln, Neb.) (114) 
2.5 FITC-Casein Protease Assay 
Total proteolytic activity was measured using fluorescein isothiocyanate (FITC) labeled 
casein (FITC-casein). Protein concentrations in culture supernatants were normalized to 
OD600 in 490 μL and combined with 320 μL of incubation buffer (40 mM Tris-HCl pH 
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7.4, 300 mM NaCl, 20 mM CaCl2, and 2 mM L-cysteine) containing factors that allow 
for the activity of all secreted proteases of S. aureus and S. epidermidis, 50 μL of 
0.2%w/v FITC-casein and milli-Q water to total a volume of 1mL. The samples were 
incubated at 37°C for 2 h. Following precipitation of undigested casein with 200 μL of 
TCA, 100 μL of solubilized FITC was combined with 100 μL of assay buffer containing 
0.5 M Tris-HCl, pH 8.5 in a microtitre plate and quantified using Cary Eclipse 
fluorometer (Varian/Agilent, Palo Alto, Calif.) at excitation 485 nm and 535 nm. Data 
was graphed using Graphpad PRISM. 
2.6. Enumeration of viable Bacteria in Co-culture 
Stock cultures were streaked onto TSA plates and single colonies were cultured into 3 
mL TSB overnight. A volume of 0.01 OD600 of both bacterial cultures were subcultured 
together into quadruplicate 125 mL flasks with 25 mL TSB alone, buffered at pH 6 or 
buffered at pH 6 supplemented with 25 μM PA, and incubated in 37°C with shaking at 
180 rpm for 18 h. At 3 h time-points, the cultures were serially diluted in TSB and 100 
uL of each culture was spread onto a TSA plate. The plates were incubated at 37°C and 
single colonies were manually counted. Colonies of the two bacteria were differentiated 
by color. Graphing and statistical analysis was performed on Graphpad PRISM. 
2.7 Phage Transduction 
Phage transduction was performed to shuttle the scpAB mutation from the 
RN6390ΔscpAB strain into the USA300 CA-MRSA strain. Transducing phage lysates 
from RN6390ΔscpAB donor cells were prepared using phage Φ80. The recipient USA300 
cells were grown in 3 ml TSB supplemented with 0.5 mM CaCl2 (TSB-C) and incubated 
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overnight in 37°C with shaking at 180 rpm. The volume equivalent of 0.1 OD600 from the 
overnight cultures was inoculated into 50 mL TSB-C and incubated at 37°C with shaking 
for 4 h. The cell culture was centrifuged and re-suspended in TSB-C to achieve 5 X 109 
cfu/mL. A volume of 0.6 mL of the cell culture and 0.6 mL of transducing phage lysates  
(5 X 109 pfu/mL) were mixed in a 15 mL tube to achieve a multiplicity of infection 
(MOI) of 1. The culture solution was incubated in room temperature for 5 min, mixed 
with 1.0 mL of 0.2 mM sodium citrate, and incubated again for 20 min. The solution was 
then centrifuged and re-suspended in 1 mL of 0.02 mM sodium citrate, following which 
200 μL was aliquoted into tubes with 3ml of top agar (9 mg yeast extract, 9 mg casamino 
acids, 17.8 mg NaCl, agar and filled to 3 mL with ddH2O) and poured onto TSA plates 
containing 0.2 mM sodium citrate, 50 μg/mL kanamycin and neomycin antibiotics. The 
plates were incubated overnight and inspected for growth. The single colonies were 
subjected to PCR for confirmation of the ΔscpAB deletion in USA300. 
2.8 Mass Spectrometry 
Protein identification was achieved through mass spectrometry at the London Regional 
Proteomics Centre at Western University. Proteins separated by SDS-PAGE and stained 
by Coomassie blue dye were excised using the EttanTM spot picker. The samples were 
processed by the Waters MASSPrep Automated Digester as described by Gyenis et. al. 
(115) The digested samples were spotted onto MALDI plates and analyzed by the 
Applied Biosystems 4700 Proteomics Analyzer. The subsequent data was viewed and 
processed by 4000 Series Explorer and Data Explorer, both Applied Biosystems 
software. The resulting peptide fingerprints were matched to protein sequences in the 
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NCBInr database via the MASCOT search engine. The protein identifications were 
assigned scores calculated by –10Log*(P), where P is the probability that the 
experimental peptide sequence’s match with the database protein sequence is a random 
event. A score of  >78 is considered significant with a p value of <0.05. 
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CHAPTER 3. RESULTS 
3.1 Acidic pH is required for optimal protease expression 
 Two characteristics of human skin that account for its antimicrobial properties include 
production of unsaturated free fatty acids (uFFA) and acidic pH. These conditions 
effectively prevent colonization of most skin pathogens (9). The CA-MRSA clone 
USA300 is one such S. aureus strain that is able to overcome these conditions and 
actively colonize and infect skin. Our lab previously found sub-inhibitory concentrations 
of uFFA to cause robust induction of the staphylococcal proteolytic cascade (SPC) in  the 
USA300 (LAC) strain. In particular, increased expression of the serine protease SspA 
was documented (80). In this study we aimed to evaluate the response of S. aureus to 
acidic pH. Our results show that USA300 grown in unbuffered TSB and TSB pH 7.0 
caused poor expression of SspA, while TSB pH 5.5 and TSB pH 6.0 caused abundant 
production (Figure 1A and 1B). To show that acidic pH selectively acts on proteases, and 
not on other virulence factors, Hla was assessed in immunoblots of the same cultures 
(Figure 1B). Although expression of Hla was attenuated in TSB pH 5.5, it was expressed 
in unbuffered TSB, TSB pH 6.0 and TSB pH 7.0. Taken together, these results 
demonstrate that acidic pH, in the range found on human skin, promotes SspA 
production. As TSB pH 6.0 depicted increased expression of SspA and not Hla when 
compared to unbuffered TSB, this pH condition was used for the majority of experiments 
in this study.  
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Figure 3.1 SDS-PAGE of secreted proteins and western blot for detection of 
SspA and alpha toxin in culture supernatants of USA300 after growth in TSB 
buffered at various pH. USA300 and USA300ΔsspA cultures were grown in 
unbuffered TSB or TSB buffered at the indicated pH and grown for 18-24 h. A) 
Protein in volumes equivalent to 3 OD600 of culture supernatants were TCA 
precipitated and the protein pellets were solubilized in SDS-loading buffer. This 
solution was loaded into an 8% acrylamide gel and subjected to SDS-PAGE prior to 
staining the gel with Coomassie blue dye for visualization. B) Protein in volumes 
corresponding to 0.05 OD600 of the culture supernatants was subjected to SDS-PAGE 
without TCA precipitation. The separated protein bands were transferred onto a 
FluoroTrans PVDF membrane and the specific proteins were detected by probing with 
indicated serum antibodies. The arrow points to the SspA bands on the SDS-PAGE 
gel. SDS-PAGE and western Blots were reproduced 3 times to confirm results. 
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3.2 Acidic pH and uFFA differentially influence growth and protease production 
in CA-MRSA and S. epidermidis.  
Given that acidic pH (Figure 3.1) and uFFA (80) cause increased expression of SspA in 
USA300, we aimed to analyze and compare the influence of acidic pH and/or uFFA on 
serine protease production and growth in USA300 and S. epidermidis. Growth of 
USA300 in TSB pH 6.0 or TSB + 25 μM PA did not demonstrate any difference when 
compared to TSB alone (Figure 3.2A-C). However, in TSB pH 6.0 + 25 μM PA, USA300 
displayed approximately a 12 h lag phase prior to unimpaired growth (Figure 3.2D). In 
contrast S. epidermidis, strain M23864:W2, grew unaffected in all the tested conditions 
(Figure 3.2A, 3.2B, 3.2C and 3.2D). Although USA300 displayed a long lag phase in the 
combined condition, total protease activity measured in 24 h culture supernatants of the 
combined condition showed the greatest activity, while protease activity in supernatants 
of TSB alone was minimal (Figure 3.3). Conversely in S. epidermidis, protease activity 
was the greatest in supernatants when grown in TSB alone and lowest in supernatants of 
the combined condition (Figure 3.3). These observations complied with the secretome 
analysis of USA300 and S. epidermidis in which USA300 exhibited most secreted SspA 
in TSB pH 6.0 + 25 μM PA, while S. epidermidis showed the greatest production of the 
extracellular serine protease  (Esp), orthologous to SspA, in TSB alone (Figure 3.4).  The 
immunodominant antigen A (IsaA) protein secreted by S. epidermidis in the combined 
conditions was indicated in Figure 3.4 to differentiate it from Esp as both proteins 
migrate to the same position on the SDS-PAGE gel. Collectively, these results show that 
USA300 growth was only hindered when exposed to acidic pH and uFFA together, 
although this condition caused the most amount of SspA production.  In contrast, S. 
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epidermidis was not affected by any of the growth conditions tested, but secreted the 
most Esp when grown in TSB alone. 
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Figure 3.2 Influence of acidic pH and unsaturated free fatty acids on growth 
of USA300 and S. epidermidis. 0.01 OD600 of overnight USA300 or M23864:W2 
cultures were inoculated into 25 mL of A) TSB alone, B) TSB pH 6.0, C) TSB + 25 
μM PA, and D) TSB pH 6.0 + 25 μM PA. Hourly OD600 values were measured until 
stationary growth phase was reached. The data were plotted using Graphpad PRISM. 
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Figure 3.3 Comparison of total protease activity in culture supernatants of 
USA300 and S. epidermidis. 0.01 OD600 volumes of USA300 and M23864:W2 
overnight cultures were inoculated into 25 mL flasks with TSB and the indicated test 
conditions. USA300 was grown for 18 h, while M23864:W2 was grown for 48 h to 
attain optimal activity. Culture supernatants were assayed for total protease activity 
using FITC labeled casein; fluorescence activity is reported in arbitrary units (AU). 
The samples were replicated 3 times to confirm results. Data was analyzed using the 
one-way Anova statistical test and graphed on Graphpad PRISM. 
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Figure 3.4 SDS-PAGE comparison of USA300 and S. epidermidis secreted 
proteins in conditions of acidic pH and uFFA. USA300 and M23864:W2 cultures 
were grown in 25 mL TSB with the indicated test conditions for 18-24 h. Protein in 
volumes equivalent to 3 OD600 culture supernatants were TCA precipitated prior to 
SDS-PAGE. The secreted protein profile was stained with Coomassie blue dye to be 
visualized. The white square symbols illustrate SspA protein bands and the white star 
symbols illustrate Esp protein bands. The white arrow points to the protein band 
corresponding to IsaA. Protein identifications were performed via mass spectrometry 
at the London Regional Proteomics Centre at Western University. SDS-PAGE was 
reproduced 3 times to confirm results. 
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3.3 USA300 is competitive with S. epidermidis during co-culture growth in TSB 
alone, and acidic pH, but not under the combination of acidic pH and uFFA.  
Our work thus far has established that USA300 increases production of SspA while S. 
epidermidis suppresses secretion of Esp in the combined conditions of acidic pH and 
uFFA, when both bacteria are grown individually. To further assess this under 
competitive conditions, we evaluated growth and protease production of S. aureus and S. 
epidermidis in co-cultures. Our results indicate that in TSB alone, USA300 outgrew S. 
epidermidis starting at the 3 h time-point (Figure 3.5A) and in TSB pH 6, USA300 
outgrew S. epidermidis at 3, 6 and 12 h. In contrast, when grown in TSB pH 6.0 + 25 μM 
PA, USA300 and S. epidermidis initially experienced a drop in cell viability at the 3 h 
time-point, after which S. epidermidis grew unhindered and achieved stationary growth 
phase by 18 h, while USA300 exhibited limited growth after 6 h, and only achieved a cell 
density equivalent to the initial inoculum by 18 h (Figure 3.5C).  SspA was expressed in 
TSB pH 6.0 and TSB + 25 μM PA co-cultures, but was not detected in TSB pH 6.0 + 25 
μM PA, where the secreted protein profile greatly resembled that of S. epidermidis 
monoculture (Figure 3.6A). Esp was also not expressed in the combined conditions 
(Figure 3.6A). Further, consistent Hla expression in all the growth conditions of USA300 
monoculture shows the differential regulation of SspA and Hla (Fig 3.6B). Together, 
these results reveal that USA300 was competitive in TSB alone and in acidic pH, but not 
in TSB pH 6.0 + 25 μM PA, when cultured with S. epidermidis. 
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Figure 3.5  Influence of acidic pH and uFFA on growth of USA300 in co-
culture with S. epidermidis. USA300 and M23864:W2 were grown in TSB 
overnight and volumes corresponding to 0.01 OD600 of both cultures were subcultured 
into 25 mL flasks of A) TSB alone, B) TSB pH 6.0 and C) TSB pH 6.0 + 25 μM PA to 
achieve a 1:1 ratio of USA300 to M23864:W2 in each flask. At 0, 3, 6, 12 and 18 h 
time-points, the cultures were serially diluted and plated on TSA plates. After a 2-day 
incubation, CFUs were enumerated. Data from 4 replicates were analyzed and graphed 
using Graphpad PRISM with t-test statistical analysis.  
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Figure 3.6  SDS-PAGE of secreted proteins and western blot analysis of  
SspA and alpha toxin in culture supernatants after growth of USA300, S. 
epidermidis and co-culture in conditions of acidic pH and unsaturated free 
fatty acids.  USA300, M23864:W2 and a 1:1 ratio co-culture of USA300 to 
M23864:W2 were grown in 25 mL of the indicated test conditions for 8 h. A) 
Proteins in volumes equivalent to 3 OD600 of the culture supernatants were TCA 
precipitated, solubilized in SDS-loading buffer and loaded into an 8% acrylamide 
gel prior to being subjected to SDS-PAGE. The gels were stained with Coomassie 
blue dye and visualized. B) Proteins in volumes corresponding to 0.05 OD600 of 
the same supernatants were subjected to SDS-PAGE without TCA precipitation 
and the separated protein bands were transferred to a FluoroTrans PVDF 
membrane and probed with serum antibodies for detection of the indicated 
proteins. SD-PAGE and western blots were repeated 3 times to confirm results. 
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3.4 Newman and SH1000 were slightly less competitive than USA300 in co-
culture with S. epidermidis. 
USA300 is a well-studied CA-MRSA strain known for causing invasive skin diseases.  
As a means to understand the influence of acidic pH on the virulence of USA300 in 
comparison to other S. aureus isolates, we analyzed the growth of S. aureus 
laboratory strains Newman and SH1000 in co-culture with S. epidermidis in acidic 
pH. In TSB pH 6.0, our results show that unlike USA300, Newman was not able to 
outgrow S. epidermidis at 3, 6, 9 and 12 h, although at the 18 h time-point, it was 
able to achieve a slightly higher cell density than S. epidermidis (Figure 3.7A). 
Conversely, S. epidermidis started to outgrow SH1000 at 6 h and by the 18 h time-
point S. epidermidis had reached greater growth than SH1000 in TSB pH 6.0 (Figure 
3.7B).  Our previous results had shown pH 5.5 to cause increased expression of SspA 
(Figure 3.1). Hence, we also tested the influence of pH 5.5 on the growth of USA300, 
Newman and SH1000 in co-culture with S. epidermidis. Our findings demonstrate 
that in pH 5.5, USA300 was able to outgrow S. epidermidis at 18 h (Figure 3.8). 
Similar to growth in pH 6.0, Newman was competitive with S. epidermidis, but with 
less significance than USA300, while SH1000 was again outgrown by S. epidermidis 
at 18 h (Figure 3.8). Collectively, these results demonstrate that in acidic pH, 
USA300 was slightly more competitive than other S. aureus strains in co-culture 
with S. epidermidis.  
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Figure 3.7 Influence of acidic pH on growth of Newman and SH1000 in co-
culture with S. epidermidis.  Newman, SH1000 and M23864:W2 were grown in TSB 
overnight.  A) Volumes corresponding to 0.01 OD600 of Newman and M23864:W2 
were sub-cultured into 25 mL flasks with TSB pH 6.0 to achieve a 1:1 ratio of 
Newman to M23864:W2 in each co-culture flask. B) Co-cultures of SH1000 and 
M23864:W2 were achieved in the same manner as A). At 0, 3, 6, 12 and 18 h time-
points, the cultures were serially diluted and plated onto TSA. After a 2-day 
incubation, CFUs were enumerated. All the samples were replicated 4 times and data 
was statistically analyzed using t-test, and graphed on Graphpad PRISM. 
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Figure 3.8 Enumeration of viable bacteria of USA300, Newman and SH1000 
in co-culture with S. epidermidis in acidic pH at 18 h. USA300, Newman, SH1000 
and M23864:W2 were grown overnight. A volume equivalent to 0.01 OD600 of each of 
the S. aureus strains were cultured with a volume corresponding to 0.01 OD600 of 
M23864:W2 into 25 mL flasks with TSB pH 5.5 to achieve a 1:1 co-culture of S. 
aureus to S. epidermidis. The co-cultures were grown for 18 h, serially diluted and 
plated onto TSA plates. After a 2-day incubation, CFUs were enumerated. All the 
samples were reproduced 4 times. Data was statistically analyzed using t-test, and 
graphed on graphpad PRISM. 
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3.5 Autolysin, Panton Valentine Leukocidin toxin and proteases are the major 
secreted proteins produced by USA300 in co-culture at pH 5.5. 
Our findings that USA300 significantly outgrew S. epidermidis in TSB pH 5.5 have led 
us to examine how growth of USA300 and S. epidermidis in co-culture reflects on the 
secreted protein profile. Our results show the two domains of the S. aureus 
autolysin, Panton-Valentine Leukocidin toxin and S. aureus proteases as the major 
secreted proteins in TSB pH 5.5 co-culture of USA300 and M23864:W2. At the 18 h 
time-point in TSB pH 5.5, USA300 was able to maintain a high cell density in co-
culture, hence the major secreted proteins in this condition are primarily produced 
by USA300.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 SDS-PAGE of secreted proteins from 18 h culture supernatants 
of USA300, S. epidermidis and co-culture in acidic pH. USA300, M23864:W2 
and a 1:1 ratio co-culture of USA300 to M23864:W2 were grown in 25 mL TSB 
pH 5.5 for 18 h. Proteins in volumes equivalent to 3 OD600 of the culture 
supernatants were TCA precipitated, solubilized in SDS-loading buffer and 
subjected to SDS-PAGE. The gels were stained with Coomassie blue dye for 
visualization. Protein identifications were performed via Mass spectrometry at the 
London Regional Proteomics Centre at Western University. SDS-PAGE was 
replicated 3 times to confirm results. 
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3.6 Although the cleavage site on S. aureus autolysin adheres to staphopain 
proteases substrate specificity, processing of the hydrolase is either not or 
exclusively mediated by SspB or ScpA. 
The autolysin protein (Atl) secreted by S. aureus constitutes the 51 kDa endo-beta-N-
acetylglucosaminidase (glucosaminidase) and 62 kDa N-acetylmuramyl-L-alanine 
amidase (amidase) domains. Atl is secreted in a precursor form that is proteolytically 
cleaved into its two active enzymes. Oshida et al. identified the cleavage site on Atl to be 
amino acids that adhere to the sequence motif highly representative of the cleavage 
preference of S. aureus staphopain proteases, SspB and ScpA (77) (See Literature 
Review Section 1.2.10). As a means to understand the role of staphopain proteases in Atl 
processing, we analyzed the secreted protein profiles of isogenic mutants of USA300. 
Our results show that the two autolysin domains are expressed separately in the secreted 
protein profile of USA300Δaur, USA300ΔsspABC, USA300ΔscpAB and 
USA300ΔaurΔsspABCΔscpAB where Aur, SspABC operon, ScpAB operon and all three 
are deleted respectively (Figure 3.10). Together, these results show that S. aureus Atl 
processing is complex and involves the activity of multiple cellular enzymes including 
ScpA and/or SspB, or is mediated by another enzyme with similar substrate specificity as 
S. aureus staphopain proteases. 
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Figure 3.10 Detection of Atl processing in SDS-PAGE of secreted proteins in 
culture supernatants of isogenic USA300 strains grown in acidic pH.  The 
indicated isogenic USA300 strains were grown in TSB pH 5.5 for 18 h. Protein in 
volumes equivalent to 3 OD600 were TCA precipitated and solubilized in SDS-loading 
buffer. The samples were loaded into an 8% acrylamide gel and subjected to SDS-
PAGE. The gel was stained with Coomassie blue dye for visualization. The proteins 
indicated using arrows were determined by mass spectrometry. Results were 
confirmed by reproducing SDS-PAGE 3 times. 
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CHAPTER 4: DISCUSSION 
S. aureus infections in the clinical and community settings have been 
meticulously investigated with the emergence of MRSA.  As S. aureus infections are 
preceded by colonization, studying S. aureus as a colonizer is crucial to understanding its 
role in pathogenesis (6). The skin maintains symbiotic relationships with a myriad of 
bacteria, of which S. epidermidis is a ubiquitous commensal (5). Consequently, in 
establishing colonization on the skin, S. aureus will always engage in niche competition 
with S. epidermidis. In this study, we manipulated the pH of TSB and supplemented it 
with uFFA as a means to analyze the influence of these antimicrobial skin conditions on 
S. epidermidis and S. aureus growth, and secreted proteins. As S. aureus is a pathogen 
while S. epidermidis is primarily a commensal, we expected that these bacteria would 
exhibit a differential response towards the conditions that would be encountered on 
human skin; namely acidic pH and uFFA.  
Our expectations were confirmed with three major observations in this study. 
Firstly, S. epidermidis was able to outgrow USA300 when cultured together in the 
condition of acidic pH and uFFA (Figure 3.5C). Secondly, when grown in acidic pH 
alone, USA300 achieved slightly superior growth but secreted an abundance of proteins 
in comparison to S. epidermidis in co-culture (Figure 3.5B and Figure 3.6). In the same 
condition, USA300 was slightly more competitive than Newman or SH1000 in co-culture 
with S. epidermidis (Figure 3.5B, Figure 3.7 and Figure 3.8). Thirdly, USA300 produced 
copious proteases in response to acidic pH and the combination of acidic pH and uFFA, 
while S. epidermidis repressed protease production under these conditions (Figure 3.4).   
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In co-culture, under the influence of acidic pH and uFFA, both S. epidermidis and 
S. aureus experienced cell death at 3 h, after which S. epidermidis was able to adapt and 
experience exponential growth, while S. aureus continued to undergo cell death until 6 h, 
after which it achieved limited growth and reached a cell density equivalent to its initial 
inoculum by 18 h (Figure 3.5C). The secreted proteins of the co-cultures in the same 
conditions reflected these findings, where the secreted protein profile was represented 
exclusively by S. epidermidis (Figure 3.6). As S. epidermidis is a skin resident 
microorganism, these results corroborate its superior adaptability to the conditions found 
on human skin compared to S. aureus.   
When cultured in acidic pH alone, USA300 was observed to show better growth 
in comparison to S. epidermidis, in co-culture (Figure 3.5B). However, acidic pH is a 
vital antimicrobial condition on the skin, and under such environmental stress, one would 
expect S. epidermidis to perform better than S. aureus. Literature suggests that the 
ACME-encoded arginine deiminsase genes, arcABDC, metabolize L-arginine and 
concomitantly release ammonia. The accumulation of intracellular ammonia is postulated 
to raise the cytoplasmic pH, allowing the bacteria to maintain pH homeostasis in acidic 
environments (61, 62). ACME is proposed to have undergone horizontal gene transfer 
from S. epidermidis into the USA300 strain of S. aureus, allowing USA300 to thrive in 
acidic conditions (61). The acquisition of ACME may permit USA300 to engage in 
effective competition with S. epidermidis on human skin. 
Analyzing the secreted proteins in the co-cultures revealed that S. aureus 
produced abundant virulence factors when grown with S. epidermidis in acidic pH or 
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uFFA alone (Figure 3.6). Secreted virulence factors including SspA are regulated by the 
Agr quorum sensing system in the post exponential growth phase. Agr comprises the 
AgrD propeptide that is modified into an autoinducing peptide (AIP) and secreted by the 
AgrB transmembrane protein. The accumulation of extracellular AIP activates the AgrC 
sensor protein, which in turn stimulates the AgrA effector protein to initiate transcription 
of RNAII, which encodes for the Agr genes, agrBDCA and RNAIII, which regulates the 
expression of virulence factors (43, 44). Previously, it was shown that the S. epidermidis 
AIP potently inhibits activity of three common S. aureus Agr types I, II and III. It was 
also demonstrated that expression of virulence factors is reduced, while growth remains 
normal when S. epidermidis supernatants are added to S. aureus cultures (106). Contrary 
to these findings, we observed that S. aureus was able to secret virulence factors even 
when grown in co-cultures with S. epidermidis (Figure 3.6). This indicates that S. 
epidermidis failed to inhibit Agr activity in USA300 (107). In our study, we grew both 
bacteria in co-culture and assessed the expression of secreted proteins, rather than 
assessing the effect of S. epidermidis supernatants on the expression of S. aureus secreted 
proteins. We found that reduced expression of S. aureus secreted virulence factors was 
only paired with the inability of USA300 to achieve normal growth when grown with S. 
epidermidis under the combination of acidic pH and uFFA (Figure 3.5C and Figure 3.6). 
Given that S. epidermidis grew to high cell densities yet failed to inhibit secretion of S. 
aureus virulence factors in acidic pH (Figure 3.6B), it is possible that not all S. 
epidermidis AIP are inhibitory towards the three common S. aureus Agr types. 
Previous studies evaluating cross-inhibition between S. aureus and S. epidermidis 
have identified only one universal AIP sequence in S. epidermidis (106, 116). However, 
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this discovery was made prior to the genome sequencing initiative undertaken by the 
Human Microbiome Project (HMP). HMP has sequenced many S. epidermidis strains, 
some of which encode the previously identified S. epidermidis AIP, while other strains of 
S. epidermidis, including the M23864:W2 strain, encode another AIP. The effects of this 
novel S. epidermidis AIP on S. aureus Agr remains to be resolved.  
USA300 was observed to be a slightly better competitor than other laboratory S. 
aureus strains when grown in co-culture with S. epidermidis. Unlike SH1000 and 
Newman, USA300 maintained greater growth than S. epidermidis from 3 to 12 h in TSB 
pH 6.0 (Figure 3.5B and Figure 3.7). In TSB pH 5.5, USA300 was able to outgrow S. 
epidermidis more than the other strains after 18 h of growth in co-culture (Figure 3.8). 
These findings may emphasize the aggressive nature of USA300 that is not seen in the 
other two S. aureus strains. Newman is characterized by a single amino acid substitution 
in which Leu18 is replaced by Pro18 in the SaeS sensory protein of the SaeRS regulatory 
system. As a result, it produces high levels of adhesion proteins and low levels of 
virulence factors (46, 117). SH1000 was constructed to correct the mutated rsbU gene, 
positive regulator of σB, in the parent strain of RN6390. Consequently, SH1000 down 
regulates exoproteins including SspA and Hla by way of reduced Agr expression (112).  
The genetic background of these strains depicts reduced virulence in comparison to 
USA300, as USA300 was shown to secrete an abundance of virulence factors in our 
study (PVL toxin, SspA, SspB and Atl) under the influence of acidic pH (Figure 3.9). 
Perhaps USA300’s amplified virulence contributes to its slight competitive advantage in 
co-culture with S. epidermidis over the other two laboratory strains. 
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We have convincingly shown acidic pH and uFFA to produce similar secreted 
protein profiles in USA300 (Figure 3.1 and Figure 3.4).  Previously, our lab showed that 
exposure to uFFA induces production of the serine protease, SspA, in USA300.  Thus far, 
uFFA was the only environmental stimulus known to cause increased production of SspA 
(80). Results from this study show both acidic pH and exogenous uFFA to similarly 
increase expression of SspA. Literature suggests that uFFA are transported across the 
bacterial membrane and incorporated into phospholipid either directly, or followed by an 
elongation process mediated by the Type II fatty acid synthase (118, 119). This has been 
proposed to increase membrane permeability and fluidity in S. aureus (80, 118).  Acidic 
pH has also been shown to alter membrane composition in other gram-positive 
organisms. As such, Listeria monocytogenes, a food borne pathogen, was demonstrated 
to increase membrane fluidity under the influence of lactic acid and shift membrane 
make-up from largely branched-chain fatty acids to straight-chain fatty acids in low pH 
conditions (120, 121). Further, Streptococcus mutans, an oral cavity pathogen, was 
demonstrated to switch membrane composition from short-chain saturated fatty acids to 
long-chain monounsaturated fatty acids in response to acidic pH (123). Both organisms 
experienced homeoviscous adaptation, previously proposed in E. coli, in which altered 
membrane composition promotes survival in suboptimal pH conditions (120, 122). Given 
that uFFA and acidic pH both produced a similar phenotype in USA300, and both stimuli 
can potentially alter membrane composition, it is plausible that acidic pH and uFFA 
trigger the same signaling pathway, leading to induction of the staphylococcal proteolytic 
cascade and subsequent production of SspA. Previously, Cassat et al. established that 
aureolysin targets and degrades alpha-type PSM peptides within the exoproteome of 
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USA300 (72). As aureolysin is required for activation of SspA, perhaps proteases are 
secreted in response to skin stimuli as a means to control expression of virulence factors 
and promote colonization (73).  
This study further observed that S. aureus increased production of SspA, while S. 
epidermidis reduced production of the orthologous Esp, in response to acidic pH alone 
and the combination of acidic pH and uFFA (Figure 3.4). This finding comes 
unexpectedly, in light of a recent study investigating the interspecies interaction between 
S. aureus and S. epidermidis during nasal colonization. Iwase et al. established that 
colonization of the nasal cavities with Esp producing S. epidermidis correlated with an 
absence of S. aureus. Additionally, purified Esp was shown to inhibit and destroy S. 
aureus biofilm via degradation of adhesion proteins associated with biofilm formation. 
With such evidence of bacterial interference, it was concluded that Esp producing S. 
epidermidis strains inhibit S. aureus nasal colonization (109). However, given our 
observation of reduced Esp secretion and activity in skin-like conditions of acidic pH and 
uFFA, Esp expression is expected to be minimal in the nasal cavities (Figure 3.3 and 
Figure 3.4). As such, Esp’s function in eradicating S. aureus nasal colonization requires 
further investigation.  Moreover, in a recent report, Krismer and Peschel determined that 
S. aureus experiences a dispersed rather than biofilm mode of growth in the anterior 
nares. Consequently Esp’s role in biofilm degradation may be redundant during 
colonization (110). Nevertheless, our results corroborate the finding that S. aureus growth 
is hindered in the presence of Esp producing S. epidermidis when grown in the 
physiologically relevant combination of acidic pH and uFFA. 
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Although we were able to mimic the interspecies competition between S. 
epidermidis and S. aureus in epithelial colonization through the manipulation of acidic 
pH and uFFA, other environmental factors such as urea, lactic acid and minerals were not 
tested. In testing the two primary antimicrobial characteristics of the skin however, we 
were able to conclusively show differences in growth and secreted proteins of S. aureus 
and S. epidermidis, specifically in response to acidic pH and uFFA. Furthermore, we 
selected the tryptic soy broth (TSB) model system for our study, as it permits expression 
of secreted virulence factors. Although TSB is a nutrient rich media and may not 
accurately represent the nutrient limitation found on skin, growth in minimal nutrient 
media would hinder growth and secretion of virulence factors (63, 124). As bacteria are 
capable of feeding on corneocyte debris for survival, TSB appears to be an adept model 
for studying bacterial growth on human skin (124).  However, our choice of bacterial 
strains used to study the commensal lifestyles of S. aureus and S. epidermidis may have 
limitations when drawing parallels between our results and previous findings. As such, 
Iwase et al. demonstrated their findings using S. aureus and S. epidermidis strains 
isolated from volunteers and patients (109) and Otto et al. assessed cross-inhibition of 
Agr pheromones with clinical S. aureus strains and the ATCC 14990 strain of S. 
epidermidis (106). In our study, we focused on the well-studied USA300 strain of S. 
aureus and the HMP characterized M23864:W2 strain of S. epidermidis. 
In furthering our understanding of the interspecies interaction between S. aureus 
and S. epidermidis, the observations in this study could be used to devise future research. 
As a means to investigate the brief period of cell death experienced by S. epidermidis and 
S. aureus when grown in co-culture under the influence of uFFA and acidic pH (Figure 
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3.5C), one can re-grow the co-culture in the same conditions to evaluate growth patterns 
and potential adaptations. In another study, comparing growth of USA300 strain with an 
isogenic ACME deletion strain in co-culture with S. epidermidis may elucidate our 
speculation that ACME contributes to a growth advantage for USA300 in acidic pH.  
Furthermore, as our work demonstrated the occurrence of an uninhibitory AIP of S. 
epidermidis towards S. aureus Agr, co-culture experiments can be performed to assess 
the variations in inhibitory activity of this S. epidermidis AIP towards different S. aureus 
strains. To further investigate the influence of S. aureus and S. epidermidis Agr activity 
in co-culture, one can compare the expression of S. aureus and S. epidermidis Agr in co-
culture to pure culture at the same cell densities. These studies will extend the findings of 
this thesis and continue to elucidate the relationship between S. aureus and S. epidermidis 
on the skin. 
Overall, our study has irrefutably shown acidic pH and uFFA to elicit differential 
responses in S. epidermidis and S. aureus. We have demonstrated that S. epidermidis 
undergoes better growth and suppresses secretion of proteases, while S. aureus 
experiences impaired growth and promotes protease expression, under the combined 
conditions of acidic pH and uFFA. Our findings imply that antimicrobial signals on the 
skin trigger the secretion of virulence factors in S. aureus that will aid in the colonization 
and invasion of host tissue, and the suppression of secreted proteins in S. epidermidis that 
allow for benign survival on the skin. In conclusion, this study has not only contributed to 
a better understanding of the co-commensal lifestyles of S. aureus and S. epidermidis, but 
has set the stage for future research of differential protein expression in commensal and 
pathogenic bacteria that may further help to understand colonization of human skin. 
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